CONTEXT: Few studies in subjects over 50 yr of age have evaluated the influence of variable doses of vitamin D supplementation on serum 25-hydroxyvitamin D levels. OBJECTIVE: We performed a meta-analysis of changes in circulating 25-hydroxyvitamin D level associated with vitamin D supplementation in Caucasian subjects over 50 yr old. DATA SOURCES: We conducted a systematic search in literature databases and in references of past reviews. STUDY SELECTION: Randomized placebo or open-label trials that evaluated the influence of vitamin D supplementation on clinical outcomes were included in the study. DATA EXTRACTION: We reviewed trial characteristics and serum 25-hydroxyvitamin D concentrations at baseline and during the trial. DATA SYNTHESIS: Seventy-six trials published from 1984 to March 2011 included 6207 subjects allocated to 101 intervention groups that tested supplement doses ranging from 5 to 250 μg/d (median, 20 μg/d). For similar doses, trials could obtain increases in 25-hydroxyvitamin D three to four times lower than other trials. A meta-regression showed that in the absence of concomitant use of calcium supplements, the average increase in serum 25-hydroxyvitamin D concentrations was 0.78 ng/ml (1.95 nmol/liter) per microgram of vitamin D3 supplement per day. Compared to the vitamin D3, the vitamin D2 was associated with significantly lower increases (P = 0.03). Concomitant use of calcium supplementation and high 25-hydroxyvitamin D concentration at baseline was nonsignificantly associated with lower increases in 25-hydroxyvitamin D concentrations. CONCLUSIONS: Dietary recommendations and randomized trials on vitamin D supplementation should evaluate whether increases in circulating 25-hydroxyvitamin D levels match expectations--for instance, the average increases obtained by trials on vitamin D3 without concomitant calcium supplements.
CONTEXT: Few studies in subjects over 50 yr of age have evaluated the influence of variable doses of vitamin D supplementation on serum 25-hydroxyvitamin D levels. OBJECTIVE: We performed a meta-analysis of changes in circulating 25-hydroxyvitamin D level associated with vitamin D supplementation in Caucasian subjects over 50 yr old. DATA SOURCES: We conducted a systematic search in literature databases and in references of past reviews. STUDY SELECTION: Randomized placebo or open-label trials that evaluated the influence of vitamin D supplementation on clinical outcomes were included in the study. DATA EXTRACTION: We reviewed trial characteristics and serum 25-hydroxyvitamin D concentrations at baseline and during the trial. DATA SYNTHESIS: Seventy-six trials published from 1984 to March 2011 included 6207 subjects allocated to 101 intervention groups that tested supplement doses ranging from 5 to 250 μg/d (median, 20 μg/d). For similar doses, trials could obtain increases in 25-hydroxyvitamin D three to four times lower than other trials. A meta-regression showed that in the absence of concomitant use of calcium supplements, the average increase in serum 25-hydroxyvitamin D concentrations was 0.78 ng/ml (1.95 nmol/liter) per microgram of vitamin D3 supplement per day. Compared to the vitamin D3, the vitamin D2 was associated with significantly lower increases (P = 0.03). Concomitant use of calcium supplementation and high 25-hydroxyvitamin D concentration at baseline was nonsignificantly associated with lower increases in 25-hydroxyvitamin D concentrations. CONCLUSIONS: Dietary recommendations and randomized trials on vitamin D supplementation should evaluate whether increases in circulating 25-hydroxyvitamin D levels match expectations--for instance, the average increases obtained by trials on vitamin D3 without concomitant calcium supplements.
Authors: Alexandra Papaioannou; Nancy Santesso; Suzanne N Morin; Sidney Feldman; Jonathan D Adachi; Richard Crilly; Lora M Giangregorio; Susan Jaglal; Robert G Josse; Sharon Kaasalainen; Paul Katz; Andrea Moser; Laura Pickard; Hope Weiler; Susan Whiting; Carly J Skidmore; Angela M Cheung Journal: CMAJ Date: 2015-09-14 Impact factor: 8.262
Authors: D P Larner; C Jenkinson; R F Chun; C S J Westgate; J S Adams; M Hewison Journal: J Steroid Biochem Mol Biol Date: 2019-01-30 Impact factor: 4.292
Authors: Yannis Manios; George Moschonis; Christina P Lambrinou; Christina Mavrogianni; Lydia Tsirigoti; Ulrich Hoeller; Franz F Roos; Igor Bendik; Manfred Eggersdorfer; Carlos Celis-Morales; Katherine M Livingstone; Cyril F M Marsaux; Anna L Macready; Rosalind Fallaize; Clare B O'Donovan; Clara Woolhead; Hannah Forster; Marianne C Walsh; Santiago Navas-Carretero; Rodrigo San-Cristobal; Silvia Kolossa; Jacqueline Hallmann; Mirosław Jarosz; Agnieszka Surwiłło; Iwona Traczyk; Christian A Drevon; Ben van Ommen; Keith Grimaldi; John N S Matthews; Hannelore Daniel; J Alfredo Martinez; Julie A Lovegrove; Eileen R Gibney; Lorraine Brennan; Wim H M Saris; Mike Gibney; John C Mathers Journal: Eur J Nutr Date: 2017-03-13 Impact factor: 5.614
Authors: Stefan Pilz; Katharina Kienreich; Femke Rutters; Renate de Jongh; Adriana J van Ballegooijen; Martin Grübler; Andreas Tomaschitz; Jacqueline M Dekker Journal: Curr Diab Rep Date: 2013-04 Impact factor: 4.810
Authors: K Uusi-Rasi; R Patil; S Karinkanta; K Tokola; P Kannus; C Lamberg-Allardt; H Sievänen Journal: Osteoporos Int Date: 2018-09-25 Impact factor: 4.507